FANJ
AZN icon

Financial Architects (New Jersey)’s AstraZeneca AZN Stock Holding History

Financial Architects (New Jersey)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-300
Closed -$3K – 890
2014
Q2 		$3K Buy
+300
New +$21.7K ﹤0.01% 828

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Financial Architects (New Jersey)'s AZN Position: Q2 2023 in Review

Financial Architects (New Jersey) held its AstraZeneca (AZN) position steady in Q2 2023 at 1,711 shares worth $245K. The position accounts for 0.04% of the portfolio, ranked #289.

Financial Architects (New Jersey) first reported a position in AZN in Q2 2013 and has held it in 32 quarters since. 1,092 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

  • Financial Architects (New Jersey) held 1,711 shares of AstraZeneca worth $245K as of Q2 2023.
  • Financial Architects (New Jersey) left its AstraZeneca share count unchanged in Q2 2023.
  • AstraZeneca made up 0.04% of Financial Architects (New Jersey)'s portfolio in Q2 2023, its #289 holding.
  • Financial Architects (New Jersey) first reported a position in AstraZeneca in Q2 2013 and has held it in 32 quarters since.
  • 1,092 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2023, filed 10 Aug 2023.